Genmab (GMAB) Earnings Analysis
Genmab (GMAB) next reports earnings on 2026-08-06, consensus EPS 0.35 USD. Last quarter (2026-05-07) it missed with EPS 0.087 USD vs 0.15 USD est (-42%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E 21.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does GMAB next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.35 USD |
| Revenue estimate | 1.11B |
GMAB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.087 USD | 0.15 USD | -42% | Miss |
| 2026-02-17 | 0.05 USD | 0.46 USD | -89.1% | Miss |
| 2025-11-06 | 0.65 USD | 0.48 USD | +35.4% | Beat |
| 2025-08-07 | 0.54 USD | 0.39 USD | +38.5% | Beat |
| 2025-02-12 | 0.57 USD | 0.28 USD | +103.6% | Beat |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
GMAB valuation and analyst view
| Trailing P/E | 21.61 |
|---|---|
| Trailing EPS | 1.34 USD |
| Price / book | 3.11 |
| Dividend yield | 0.00% |
| Market cap | 17.82B |
| Analyst consensus | Buy (13 buy / 4 hold / 1 sell) |
| Avg price target | 40.33 USD |
Related research pages
Frequently asked questions
When is Genmab (GMAB)'s next earnings date?
Genmab is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.35 USD and revenue estimate of 1.11B.
Did GMAB beat earnings last quarter?
In its 2026-05-07 report, GMAB posted EPS of 0.087 USD versus a 0.15 USD estimate — a miss of 42%.
What is GMAB's earnings track record?
Over the last 5 reported quarters with consensus data, GMAB beat estimates 3 times (60%).
What is GMAB's current P/E ratio and EPS?
GMAB trades at a trailing P/E of 21.61 on trailing EPS of 1.34 USD.
What do analysts rate GMAB?
Analyst consensus is "Buy" across 18 ratings (0 strong buy, 13 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 40.33 USD.